ICV administration of CRF blocker (CRF(9-41 δ) helical) reduces morphine withdrawal in rats

  • Sara Brugger
  • , Rosa Sanchez
  • , Arturo J. Brugger
  • , Jose Antonio Martinez*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Abstract

1. The effects of CRF(9-41 δ) helical on morphine withdrawal signs in rats were studied 2. Intracerebroventricular administration of CRF(9-41 δ) helical 5 at 10 μg/kg reduced central and peripheral symptons of the withdrawal syndrome, such as ptosis, jumping, wet dog shakes and teeth chatering; other signs remained unchanged. The effect were not dose dependent. 3. The hypothermi characteristic of the Withdrawal syndrome was reduced by CRF(9-41 δ) helical. 4. These results suggest that the hypothalamo pituitary adrenal(HPA) axis play an important role in the morphine withdrawal syndrome in rats.

Original languageEnglish
Pages (from-to)775-785
Number of pages11
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume22
Issue number5
DOIs
Publication statusPublished - Jul 1998
Externally publishedYes

Keywords

  • CRF(9-41 δ) helical antagonist
  • Hypothalamo pituitary -adrenal axis
  • Morphine withdrawal syndrome
  • Opoid

Fingerprint

Dive into the research topics of 'ICV administration of CRF blocker (CRF(9-41 δ) helical) reduces morphine withdrawal in rats'. Together they form a unique fingerprint.

Cite this